regulatory
confidence high
sentiment negative
materiality 0.65
Aptinyx Inc.: Nasdaq/NYSE listing notice — Aptinyx transfers listing to Nasdaq Capital Market; gets 180-day cure for bid price non-compliance
Aptinyx Inc.
- Transfer from Nasdaq Global Select to Capital Market effective Dec 9, 2022; stock symbol remains APTX.
- Received additional 180-day period until June 5, 2023 to regain $1.00 minimum bid price compliance.
- Also non-compliant on audit committee composition (needs 3 independent directors) due to Patrick Enright resignation; cure until Nov 30, 2023 or next annual meeting.
- Company may consider reverse stock split to cure bid price deficiency; no assurance of success.